Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|10|1|10-33

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.10, Iss.1, 2015-04, pp. : 10-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications

By  

Current Diabetes Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-106

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 236-240

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products and Cardiovascular Disease

By  

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 92-100

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Prevents Latent Skin Lesions by Inhibiting the Generation of Advanced Glycation End Products in Streptozotocin-Induced Diabetic Rats

By Chen Xiangfang   Lin Weidong   Lu Shuliang   Shi Yongquan   Zou Junjie   Liu Zhimin   Liao Wanqing  

Endocrine Pathology, Vol. 20, Iss. 3, 2009-09 ,pp. : 163-169

Humana Press, Inc

Access to resources Recommend Favorite

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina

By Hughes J.   Kuiper E.   Klaassen I.   Canning P.   Stitt A.   Bezu J.   Schalkwijk C.   Noorden C.   Schlingemann R.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1089-1098

Springer Publishing Company

Access to resources Recommend Favorite